Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 12, 2024. (Total: 234319Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Alzheimer Disease and CYP2D6[original query]
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.
Neurology 2009 Sep 73 (10): 761-7.
Pilotto Alberto, Franceschi M, D'Onofrio G, Bizzarro A, Mangialasche F, Cascavilla L, Paris F, Matera M G, Pilotto Andrea, Daniele A, Mecocci P, Masullo C, Dallapiccola B, Seripa
Effect of CYP2D6*10 and APOE polymorphisms on the efficacy of donepezil in patients with Alzheimer's disease.
The American journal of the medical sciences 2013 Mar 345 (3): 222-6.
Zhong Yuan, Zheng Xueli, Miao Ya, Wan Lili, Yan Hong, Wang Beiy
Association between inherited CYP2D6/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs.
Therapeutic drug monitoring 2014 Feb 36 (1): 125-30.
Kersten Hege, Wyller Torgeir B, Molden Esp
Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population.
Journal of geriatric psychiatry and neurology 2014 Feb 27 (2): 119-127.
Singh Neeraj Kumar, Banerjee B D, Bala Kiran, Basu Mitra, Chhillar Neel
Impact of CYP2D6, CYP3A5, and ABCB1 Polymorphisms on Plasma Concentrations of Donepezil and Its Metabolite in Patients With Alzheimer Disease.
Therapeutic drug monitoring 2020 Oct .
Kagawa Yoshiyuki, Yamamoto Yoshiaki, Ueno Ayami, Maeda Toshio, Obi Tomoka
TOP